Trial · NCT01518634
Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome
NCT01518634, Phase 2, Completed, University of Aarhus
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome. Trials, record NCT01518634. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01518634
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome
- NCT number
- NCT01518634
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 138 participants, actual
- Lead sponsor
- University of Aarhus
- Conditions
- Somatisation Disorder, Somatoform Disorders
- Interventions
- Imipramine treatment, Placebo
- First posted
- 2012-01-26
- Last updated
- 2017-05-09
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Global Clinical Improvement Scale | After 13 weeks | Questionnaire, patient-rated improvement of health since the beginning of the study. |
| Secondary | SF-36 | At 1 and 13 weeks | Questionnaire, patient-rated. Assessment of physical, social and mental functioning |
| Secondary | Visual Analogue Scale for pain and worst symptom | At 1 and 13 weeks | |
| Secondary | Symptom Checklist (SCL) | At 1, 3 and 13 weeks | |
| Secondary | Functional Illness Checklist (FIC) | At 1, 3 and 13 weeks | |
| Secondary | WHODAS II | At 1 and 13 weeks |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 28408193 | RESULT |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01518634
GET https://conductscience.org/api/trials/v1/NCT01518634/registered